Shares of Cara Therapeutics, Inc. (NASDAQ:CARA – Get Free Report) have been given an average recommendation of “Hold” by the five brokerages that are covering the firm, Marketbeat reports. Five analysts have rated the stock with a hold recommendation. The average 1-year price objective among brokerages that have updated their coverage on the stock in […]

Shares of Vera Therapeutics, Inc. (NASDAQ:VERA – Get Free Report) have received an average rating of “Buy” from the nine research firms that are presently covering the company, MarketBeat reports. One analyst has rated the stock with a hold rating, six have issued a buy rating and two have given a strong buy rating to […]